Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Unlisted share news
  3. 'Should have thought about debt but...' Pharmeasy CEO Siddharth Shah op…

'Should have thought about debt but...' Pharmeasy CEO Siddharth Shah opens up about Thyrocare acquisition

19 Jan 2024

Add as preferred source
Key Takeaways

  • Strategic Alignment Stand:

    • Despite admitted missteps, the CEO stands by Thyrocare acquisition's strategic alignment.

  • Commitment Signal:

    • Rights Issue signals commitment backed by significant employee investment for shareholder value.

  • Sustainable Growth Priority:

    • Prioritizing sustainable growth over rapid expansion, leveraging a substantial repeat customer base for future success.

  • Strategic Alignment Stand:

    • Despite admitted missteps, the CEO stands by Thyrocare acquisition's strategic alignment.

  • Commitment Signal:

    • Rights Issue signals commitment backed by significant employee investment for shareholder value.

  • Sustainable Growth Priority:

    • Prioritizing sustainable growth over rapid expansion, leveraging a substantial repeat customer base for future success.

pharmeasy unlisted shares

API Holdings (Pharmeasy)

-8.09%

Expert Analysis

Pharmeasy CEO Defends Thyrocare Acquisition, Acknowledges Oversight, and Emphasizes Commitment to Sustainable Growth and Shareholder Value

Expert Analysis:

  • Strategic Defense:

    • Pharmeasy CEO justifies Thyrocare acquisition for strategic fit and digital growth potential.

  • Learning from Oversight:

    • Acknowledge oversight on debt, and I want you to know that I'm committed to learning from my mistakes.

  • Shareholder Dedication:

    • Rights Issue, with Rs 132 crore employee investment, underscores dedication to shareholder benefits.

  • Sustainable Growth Focus:

    • Focus on sustainable growth aligns with evolving market dynamics.

  • Repeat Customer Leverage:

    • With 77% revenue from repeat customers, it expects improved operating leverage for Pharmeasy.

Publisher:ET Now